We are live on ! Find out more
EIP

Epoch Investment Partners Portfolio holdings

AUM $16.5B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
-5.93%
1 Year Est. Return
+24.3%
3 Year Est. Return
+77.95%
5 Year Est. Return
+103.29%
10 Year Est. Return
+404.8%
AUM
$25.8B
AUM Growth
-$1.27B
Cap. Flow
+$795M
Cap. Flow %
3.08%
Top 10 Hldgs %
20.21%
Holding
281
New
14
Increased
121
Reduced
123
Closed
20

Sector Composition

Rank Sector Weight
1 Financials 17.55%
2 Technology 14.87%
3 Healthcare 13.57%
4 Industrials 9.07%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYF icon
26
Synchrony
SYF
$25.6B
$313M 1.21%
9,987,047
+431,989
+5% +$14.3M
WELL icon
27
Welltower
WELL
$171B
$312M 1.21%
4,608,041
+370,044
+9% +$24.7M
VZ icon
28
Verizon
VZ
$196B
$311M 1.21%
7,158,782
+1,112,798
+18% +$51.3M
RAI
29
DELISTED
Reynolds American Inc
RAI
$298M 1.16%
6,736,801
-3,800,379
-36% -$158M
PEP icon
30
PepsiCo
PEP
$190B
$291M 1.13%
3,089,731
+433,853
+16% +$41.3M
KMI icon
31
Kinder Morgan
KMI
$68.7B
$290M 1.13%
10,488,762
+2,771,658
+36% +$91.8M
LUMN icon
32
Lumen
LUMN
$6.44B
$285M 1.11%
11,343,783
+595,300
+6% +$16.5M
MO icon
33
Altria Group
MO
$114B
$285M 1.1%
5,234,196
-1,155,741
-18% -$62M
TE
34
DELISTED
TECO ENERGY INC
TE
$280M 1.09%
10,670,234
-508,459
-5% -$11.4M
PPL
35
PPL Corp
PPL
$26.7B
$279M 1.08%
8,471,508
+665,730
+9% +$20.8M
IRM icon
36
Iron Mountain
IRM
$36.1B
$262M 1.02%
8,451,544
+3,738,592
+79% +$112M
CME icon
37
CME Group
CME
$94.8B
$259M 1%
2,788,930
+69,399
+3% +$6.6M
AMAT icon
38
Applied Materials
AMAT
$428B
$252M 0.98%
17,131,982
+127,600
+0.8% +$2.13M
AZN icon
39
AstraZeneca
AZN
$250B
$245M 0.95%
3,850,189
+318,702
+9% +$21M
CFG icon
40
Citizens Financial Group
CFG
$30.6B
$242M 0.94%
10,129,103
+248,007
+3% +$6.34M
RDS.A
41
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$228M 0.88%
5,068,116
+432,096
+9% +$22M
AMP icon
42
Ameriprise Financial
AMP
$48.8B
$228M 0.88%
2,085,677
+469,666
+29% +$55.4M
ETR icon
43
Entergy
ETR
$50B
$227M 0.88%
6,959,974
+1,800,592
+35% +$61.1M
POT
44
DELISTED
Potash Corp Of Saskatchewan
POT
$226M 0.88%
11,013,424
+2,862,533
+35% +$75.1M
CXW icon
45
CoreCivic
CXW
$3.19B
$196M 0.76%
6,623,545
+529,802
+9% +$17M
AEE icon
46
Ameren
AEE
$30.1B
$195M 0.76%
4,614,041
-1,954,007
-30% -$78.7M
COP icon
47
ConocoPhillips
COP
$141B
$190M 0.74%
3,952,789
+1,105,672
+39% +$56.3M
BLK icon
48
Blackrock
BLK
$176B
$182M 0.71%
611,197
-14,751
-2% -$4.76M
C icon
49
Citigroup
C
$226B
$181M 0.7%
3,653,608
-140,393
-4% -$7.67M
TWX
50
DELISTED
Time Warner Inc
TWX
$178M 0.69%
2,591,863
-101,278
-4% -$7.96M

Similar funds

Epoch Investment Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Epoch Investment Partners held 281 positions worth $25.8B, down 4.7% from $27.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Epoch Investment Partners deployed $795M of net new capital in Q3 2015, opening 14 new positions and adding to 121 existing holdings. Its largest new stake was Teva Pharmaceuticals: 2,899,740 shares worth $164M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Check Point Software Technologies, an estimated $252M trimmed.

  • Epoch Investment Partners's largest Q3 2015 buy was Teva Pharmaceuticals: 2,899,740 shares worth $164M.
  • Epoch Investment Partners added most to GE Aerospace in Q3 2015, an estimated $425M increase.
  • Epoch Investment Partners's biggest Q3 2015 reduction was Check Point Software Technologies, cutting an estimated $252M.
  • Epoch Investment Partners fully exited Agilent Technologies in Q3 2015, selling an estimated $129M.
  • Epoch Investment Partners's ten largest holdings make up 20% of its $25.8B portfolio in Q3 2015.
  • Epoch Investment Partners opened 14 new positions and closed 20 in Q3 2015.
  • Epoch Investment Partners's portfolio value fell 4.7% quarter-over-quarter to $25.8B.

Based on Epoch Investment Partners's 13F filing for Q3 2015, filed 13 Nov 2015.